| Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl E Weisberg, PW Manley, W Breitenstein, J Brüggen, SW Cowan-Jacob, ... Cancer cell 7 (2), 129-141, 2005 | 1938 | 2005 |
| Lin28 promotes transformation and is associated with advanced human malignancies SR Viswanathan, JT Powers, W Einhorn, Y Hoshida, TL Ng, S Toffanin, ... Nature genetics 41 (7), 843-848, 2009 | 956 | 2009 |
| Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL M Azam, RR Latek, GQ Daley Cell 112 (6), 831-843, 2003 | 773 | 2003 |
| Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors J Zhang, FJ Adrián, W Jahnke, SW Cowan-Jacob, AG Li, RE Iacob, T Sim, ... Nature 463 (7280), 501-506, 2010 | 693 | 2010 |
| Activation of tyrosine kinases by mutation of the gatekeeper threonine M Azam, MA Seeliger, NS Gray, J Kuriyan, GQ Daley Nature structural & molecular biology 15 (10), 1109-1118, 2008 | 503 | 2008 |
| Interleukin‐3 signals through multiple isoforms of Stat5. M Azam, H Erdjument‐Bromage, BL Kreider, M Xia, F Quelle, R Basu, ... The EMBO journal 14 (7), 1402-1411, 1995 | 414 | 1995 |
| Disruption of the mouse μ-calpain gene reveals an essential role in platelet function M Azam, SS Andrabi, KE Sahr, L Kamath, A Kuliopulos, AH Chishti Molecular and cellular biology, 2001 | 327 | 2001 |
| Mechanisms and implications of imatinib resistance mutations in BCR-ABL V Nardi, M Azam, GQ Daley Current opinion in hematology 11 (1), 35-43, 2004 | 263 | 2004 |
| The secreted tumor-associated antigen 90K is a potent immune stimulator A Ullrich, I Sures, M D'Egidio, B Jallal, TJ Powell, R Herbst, A Dreps, ... Journal of Biological Chemistry 269 (28), 18401-18407, 1994 | 243 | 1994 |
| Functionally distinct isoforms of STAT5 are generated by protein processing M Azam, C Lee, I Strehlow, C Schindler Immunity 6 (6), 691-701, 1997 | 194 | 1997 |
| Oxalate decarboxylase from Collybia velutipes: molecular cloning and its overexpression to confer resistance to fungal infection in transgenic tobacco and tomato M Kesarwani, M Azam, K Natarajan, A Mehta, A Datta Journal of Biological Chemistry 275 (10), 7230-7238, 2000 | 176 | 2000 |
| Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance M Azam, V Nardi, WC Shakespeare, CA Metcalf III, RS Bohacek, Y Wang, ... Proceedings of the National Academy of Sciences 103 (24), 9244-9249, 2006 | 129 | 2006 |
| Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: A prospective randomized study S Chattopadhyay, A Saha, M Azam, A Mukherjee, PK Sur South Asian journal of cancer 3 (01), 008-012, 2014 | 108 | 2014 |
| The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. G Gupta, M Azam, L Yang, RS Danziger The Journal of clinical investigation 100 (6), 1488-1492, 1997 | 105 | 1997 |
| Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia M Kesarwani, Z Kincaid, A Gomaa, E Huber, S Rohrabaugh, Z Siddiqui, ... Nature medicine 23 (4), 472-482, 2017 | 101 | 2017 |
| Cytokines and growth factors signal through tyrosine phosphorylation of a family of related transcription factors P Rothman, B Kreider, M Azam, D Levy, U Wegenka, A Eilers, T Decker, ... Immunity 1 (6), 457-468, 1994 | 101 | 1994 |
| Factors influencing halal products purchase intention in India: preliminary investigation A Khan, MK Azam IUP Journal of Marketing Management 15 (1), 20, 2016 | 99 | 2016 |
| Headpiece domain of dematin is required for the stability of the erythrocyte membrane R Khanna, SH Chang, S Andrabi, M Azam, A Kim, A Rivera, C Brugnara, ... Proceedings of the National Academy of Sciences 99 (10), 6637-6642, 2002 | 93 | 2002 |
| Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRα, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants E Weisberg, HG Choi, A Ray, R Barrett, J Zhang, T Sim, W Zhou, ... Blood, The Journal of the American Society of Hematology 115 (21), 4206-4216, 2010 | 83 | 2010 |
| Targeted inhibition of the dual specificity phosphatases DUSP1 and DUSP6 suppress MPNST growth via JNK A Ramkissoon, KE Chaney, D Milewski, KB Williams, RL Williams, K Choi, ... Clinical Cancer Research 25 (13), 4117-4127, 2019 | 74 | 2019 |
